Last $28.00 USD
Change Today -0.50 / -1.75%
Volume 6.5K
AMAVF On Other Exchanges
Symbol
Exchange
OTC US
Stockholm
Frankfurt
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

arcam ab (AMAVF) Snapshot

Open
$28.00
Previous Close
$28.50
Day High
$28.33
Day Low
$27.82
52 Week High
01/23/14 - $50.25
52 Week Low
07/26/13 - $16.18
Market Cap
513.6M
Average Volume 10 Days
21.5K
EPS TTM
--
Shares Outstanding
18.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ARCAM AB (AMAVF)

Related News

No related news articles were found.

arcam ab (AMAVF) Related Businessweek News

No Related Businessweek News Found

arcam ab (AMAVF) Details

Arcam AB (publ) provides additive manufacturing solutions for the production of metal components. The company offers Arcam Q10, an electron beam melting (EBM) machine for the industrial production of orthopedic implants; Arcam Q20 to manufacture wide range of aerospace-related components, such as turbine blades and structural airframe components; and Arcam A2X to process titanium alloys and materials that require elevated process temperatures, such as titanium aluminide. It also provides software; metal powders; powder handling auxiliary equipment, including explosion-protected vacuum cleaners, powder handling trolleys, and powder recovery systems; and service and application support, and training services. The company serves orthopedic implant and aerospace industries primarily in the United States and Europe. Arcam AB (publ) was founded in 1997 and is headquartered in Gothenburg, Sweden.

113 Employees
Last Reported Date: 07/18/14
Founded in 1997

arcam ab (AMAVF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

arcam ab (AMAVF) Key Developments

Arcam AB Reports Audited Group and Parent Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Arcam AB reported audited group and parent earnings results for the second quarter and six months ended June 30, 2014. For the quarter, on group basis, the company reported net sales of SEK 46.1 million, compared to SEK 54.0 million for the last year. Operating loss was SEK 6.1 million, compared to operating profit of SEK 6.5 million for the last year. Net profit for the period was SEK 0.4 million, compared to SEK 7.5 million for the last year. Earning per share after dilution was SEK 0.02 compared to SEK 0.47 million for the last year. Cash flow from operations was SEK 10.9 million, compared to SEK 19.0 million for the last year. Investment in intangible assets was SEK 0.5 million, compared to SEK 0.2 million for the last year. Investment in tangible assets was SEK 2.4 million. Return on equity was 0.7% compared to 5.2% for the last year. For the six months, on group basis, the company reported net sales of SEK 111 million, compared to SEK 92.1 million for the last year. Operating loss was SEK 3.8 million, compared to operating profit of SEK 7.0 million for the last year. Net profit for the period was SEK 3.9 million, compared to SEK 7.6 million for the last year. Earning per share after dilution was SEK 0.21 compared to SEK 0.48 million for the last year. Cash flow from operations was SEK 2.8 million, compared to SEK 29.4 million for the last year. Investment in intangible assets was SEK 0.9 million, compared to SEK 0.6 million for the last year. Investment in tangible assets was SEK 3.7 million, compared to SEK 0.3 million for the last year. For the quarter, on parent basis, the company reported net sales of SEK 35.6 million, compared to SEK 53.4 million for the last year. Operating loss was SEK 6.1 million, compared to operating profit of SEK 7.5 million for the last year. Net profit for the period was SEK 2.4 million, compared to SEK 8.5 million for the last year. Earning per share after dilution was SEK 0.13 compared to SEK 0.53 million for the last year. For the six months, on parent basis, the company reported net sales of SEK 99.2 million, compared to SEK 90.9 million for the last year. Operating income was SEK 1.8 million, compared to SEK 6.5 million for the last year. Net profit for the period was SEK 7.1 million, compared to SEK 7.8 million for the last year. Earning per share after dilution was SEK 0.38 compared to SEK 0.50 million for the last year.

Arcam AB, Q2 2014 Earnings Call, Jul 18, 2014

Arcam AB, Q2 2014 Earnings Call, Jul 18, 2014

Arcam Receives Order for Two Arcam Q10 Systems

Arcam has received an order for two Arcam Q10 systems from the strategic partner DiSanto Technology Inc. in the US. The systems will be used for manufacturing of orthopedic implants. In spring 2013 Arcam and Disanto Technology Inc. entered into a strategic cooperation in order to make a joint development of customers for contract manufacturing of advanced orthopedics implants based on Arcam´s EBM technology. In connection with the cooperation DiSanto bought two EBM systems. With this new order DiSanto increases its EBM based production.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMAVF:US $28.00 USD -0.50

AMAVF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Renishaw PLC 1,899 GBp +51.00
SLM Solutions Group AG €19.98 EUR -0.02
View Industry Companies
 

Industry Analysis

AMAVF

Industry Average

Valuation AMAVF Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARCAM AB, please visit www.arcam.se. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.